In addition, in CLL, ZAP-70 positive patients have significantly higher CCL3 and CCL4 plasma levels (43), and CCL3 plasma levels correlate with other risk factors (44). This evidence concerns the gene CCL4 and B-cell chronic lymphocytic leukemia.